Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (2016 - 2025)

Bio-Techne has reported Shares Outstanding over the past 17 years, most recently at $155.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $155.9 million for Q4 2025, down 1.29% from a year ago — trailing twelve months through Dec 2025 was $155.9 million (down 1.29% YoY), and the annual figure for FY2025 was $155.0 million, down 2.05%.
  • Shares Outstanding for Q4 2025 was $155.9 million at Bio-Techne, roughly flat from $155.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for TECH hit a ceiling of $158.9 million in Q3 2024 and a floor of $38.9 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $157.1 million (2021), compared with a mean of $151.2 million.
  • Biggest five-year swings in Shares Outstanding: surged 306.96% in 2021 and later dropped 2.05% in 2025.
  • Bio-Techne's Shares Outstanding stood at $157.3 million in 2021, then dropped by 0.12% to $157.1 million in 2022, then grew by 0.03% to $157.1 million in 2023, then grew by 0.49% to $157.9 million in 2024, then dropped by 1.29% to $155.9 million in 2025.
  • The last three reported values for Shares Outstanding were $155.9 million (Q4 2025), $155.7 million (Q3 2025), and $155.0 million (Q2 2025) per Business Quant data.